Симона Бен-Хаим

Отделение: Ядерная медицина
Должность: Радиолог
Языки: Английский
Принимает: только взрослых

Профессор Симона Бен-Хаим - заведующая отделением ядерной медицины.

Научные публикации

Worldwide Radiation Dose in Coronary Artery Disease Diagnostic Imaging
Outcomes of Lobar and Sublobar Resection for Clinical Stage I Lung Neuroendocrine Tumors: An ENETS Center of Excellence Experience
Update in the Management of ACTH-Secreting Gastroenteropancreatic and Thoracic Neuroendocrine Neoplasms
The relevance of nomograms for prediction of pelvic lymph node metastases in the prostate-specific membrane antigen (PSMA)-PET/CT era
Clinical use of inpatient FDG-PET/CT in internal medicine
Correction to: Guiding principles on the education and practice of theranostics
Pelvic lymph node mapping in prostate cancer: examining the impact of PSMA PET/CT on radiotherapy decision-making in patients with node-positive disease
Distribution and predictors of F-18-FDG uptake values of non-malignant cervical lymph nodes in pediatric patients
Prostate Cancer Radioligand Therapy: Beta-labeled Radiopharmaceuticals
Delayed levodopa-responsive parkinsonism following acute midbrain injury
Guiding principles on the education and practice of theranostics
99mTc MIBI Scintigraphy for Classification of Amiodarone-induced Thyrotoxicosis
Impact of Single-Time-Point Estimates of 177Lu-PRRT Absorbed Doses on Patient Management: Validation of a Trained Multiple-Linear-Regression Model in 159 Patients and 477 Therapy Cycles
Towards accurate 177Lu SPECT activity quantification and standardization using lesion-to-background voxel ratio
False Positive Findings of [18F]PSMA-1007 PET/CT in Patients After Radical Prostatectomy with Undetectable Serum PSA Levels
Sentinel Lymph Node Identification in Cutaneous Head & Neck Cancer - Lymphoscintigraphy Late Phase
Levodopa-responsive dystonia caused by biallelic PRKN exon inversion invisible to exome sequencing
Quantitative SPECT/CT parameters of myocardial 99mTechnetium-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) uptake in suspected cardiac transthyretin amyloidosis
Simple model for estimation of absorbed dose by organs and tumors after PRRT from a single SPECT/CT study
Lessons Learned from Post-COVID-19 Vaccination PET/CT Studies
RADIONUCLIDE THERAPY OF NEUROENDOCRINE TUMORS - IMPROVEMENTS IN THE PROTOCOL FOR MEASUREMENT OF PATIENT RADIATION EXPOSURE
Carried away with the flow to maintain the reserve
Efficacy and Safety of 177Lu-DOTATATE in Lung Neuroendocrine Tumors: A Bicenter study
PET/CT in breast cancer staging is useful for evaluation of axillary lymph node and distant metastases
Perceptual omission errors in positron emission tomography and computed tomography reporting
Can a penalized-likelihood estimation algorithm be used to reduce the injected dose or the acquisition time in 68Ga-DOTATATE PET/CT studies?
VHL-Related Neuroendocrine Neoplasms And Beyond: An Israeli Specialized Center Real-Life Report
The Israel Registry for Alzheimer's Prevention (IRAP) Study: Design and Baseline Characteristics
Variability in bone-seeking tracers and imaging protocols for the diagnosis of cardiac amyloidosis: The more the merrier?
A Retrospective Analysis of the Safety and Activity of Lutetium-177-Prostate-Specific Membrane Antigen Radionuclide Treatment in Older Patients with Metastatic Castration-Resistant Prostate Cancer
A double-blind placebo-controlled clinical trial testing the effect of hyperbaric oxygen therapy on brain and cognitive outcomes of mildly cognitively impaired elderly with type 2 diabetes: Study design
PET/CT in Disease Detection and Follow-up of Subcutaneous Involvement in Marginal Zone Lymphoma
Long-term outcomes in MEN-1 patients with pancreatic neuroendocrine neoplasms: an Israeli specialist center experience
Efficacy of Peptide Receptor Radionuclide Therapy for Esthesioneuroblastoma
Dosimetry after peptide receptor radionuclide therapy: impact of reduced number of post-treatment studies on absorbed dose calculation and on patient management
Gallium-68 prostate-specific membrane antigen PET-CT and the clinical management of prostate cancer
Fluorodeoxyglucose Detected Changes in Brain Metabolism After Chemotherapy in Pediatric Non-Hodgkin Lymphoma
68Ga-PSMA PET/CT in prostate cancer patients - patterns of disease, benign findings and pitfalls
Feasibility study of a novel general purpose CZT-based digital SPECT camera: initial clinical results
Low rate of spleen involvement in sporadic Burkitt lymphoma at staging on PET-CT
Fat necrosis after abdominal surgery: A pitfall in interpretation of FDG-PET/CT
Physiologic uptake of 18F-FDG in transposed ovaries may mimic metastasis on 18F-FDG PET/CT imaging
Use of 18F-FDG PET-CT imaging to determine internal mammary lymph node location for radiation therapy treatment planning in breast cancer patients
FDG PET-CT evaluation in neurolymphomatosis: imaging characteristics and clinical outcomes
Erratum to: Performance of cardiac cadmium-zinc-telluride gamma camera imaging in coronary artery disease: a review from the cardiovascular committee of the European Association of Nuclear Medicine (EANM)
Performance of cardiac cadmium-zinc-telluride gamma camera imaging in coronary artery disease: a review from the cardiovascular committee of the European Association of Nuclear Medicine (EANM)
What are the necessary corrections for dynamic cardiac SPECT?
Focal fluorine-18 fluorodeoxyglucose-avid parotid findings in patients with lung cancer: prevalence and characteristics
Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?
Показать ещё 41 статью Скрыть статьи
Заболевания
Нейроэндокринные опухоли
Эстезионейробластома
Процедуры
ПЭТ-диагностика для оценки риска Альцгеймера
Пептид-рецепторная радионуклидная терапия
Позитронно-эмиссионная томография (ПЭТ-КТ)
Координатор «Хадассы» поможет подобрать врача
Остались вопросы?
Напишите нам и мы свяжемся с вами в течение ближайшего времени и ответим на все интересующие вопросы